Varonis Systems heads into its July 27 earnings report with analysts raising targets aggressively and the stock sitting on a 38% one-month gain — yet the stock lost ground this week, even as the Street turned materially more bullish.
The analyst story is the loudest signal right now. UBS lifted its target from $37 to $58 on Tuesday, maintaining Buy, while Truist raised from $34 to $52 on the same day. Wells Fargo moved to $50 from $35 the day before. Those three moves came within 48 hours and follow Barclays and TD Cowen each raising to $52 and $50 respectively last week. The consensus mean price target now runs near $44.73 — already behind where the stock traded earlier this month — which tells you the Street is scrambling to catch up with a stock that re-rated faster than the upgrade cycle. The bull case centres on Varonis's SaaS transition, AI-driven data security demand, and persistent acquisition speculation. Bears counter that broadening the customer base while competing against larger, well-capitalised rivals is harder than the current multiple implies, and that deal conversion metrics need to hold up in the print.
The valuation has re-rated sharply. The EV/EBITDA multiple recently exceeded 99x, though it has compressed about 12 points over the past 30 days as the price pulled back from its peak. The price-to-earnings multiple remains elevated at roughly 174x. Factor scores are more encouraging on the earnings side — EPS surprise ranks at the 97th percentile, 90-day EPS momentum at the 94th — both suggesting the company has a strong recent track record of beating estimates. The short score of 42.2 and a short score rank at the 37th percentile confirm there is no meaningful bearish conviction baked in from a systematic perspective.
Positioning in the lending market is about as loose as it gets. Availability runs at over 3,200% — meaning shares available to borrow are roughly 32 times the current short interest — and the 52-week low availability was still above 700%, so borrow has never been tight on this name. Short interest itself, at 6.4% of the free float, has fallen more than 21% over the past month. Around 1.5 million shares came out of short positions in a single step around July 10, a visible de-risking that coincides with the stock's strong run. Cost to borrow ticked up 25% this week to 0.57%, but from an already negligible base — the absolute level remains low by any standard. Options positioning is neutral: the put/call ratio of 0.62 sits almost exactly in line with its 20-day average, with a z-score near zero. There is no defensive hedge-building visible in the options market ahead of earnings.
The earnings reaction history is worth noting. The last three prints produced day-one moves of roughly +5%, +3.4%, and +8.9%, all positive. Five-day returns were more mixed — the most recent quarter saw the stock retrace to a five-day loss of 3.3% despite the initial pop. With the stock having already rallied 38% in a month ahead of the print, the bar for the market to reward a beat is meaningfully higher than in prior quarters. Peer stocks had a rough week: TENB dropped 20%, RBRK fell 14%, and QLYS declined 12%, while VRNS gave back just 4.2% — relative resilience that reflects either conviction ahead of the number or thinner liquidity in the shares-to-borrow pool than the headline availability figure implies.
The July 27 print is therefore less about whether Varonis can sustain ARR growth and more about whether the SaaS transition metrics — net revenue retention, new logo adds, cloud ARR mix — can justify a multiple that has more than doubled in a month while the analyst community is still revising targets higher in real time.
See the live data behind this article on ORTEX.
Open VRNS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
